Works matching DE "SORAFENIB"

Results: 1692

Neoadjuvant Multikinase Inhibitor Therapy in Locally Advanced Unresectable Differentiated Thyroid Carcinoma: a Case Report.

Published in:

Indian Journal of Surgery, 2024, v. 86, p. 250, doi. 10.1007/s12262-022-03649-0

By:

Sharanappa, Vikram;
Pradhan, Sushobhan;
Mishra, Anjali;
Pradhan, Prasanta Kumar

Publication type:

Article

Case Series Analysis of Malignant Struma Ovarii with Lung Metastases.

Published in:

Indian Journal of Surgery, 2023, v. 85, p. 515, doi. 10.1007/s12262-023-03818-9

By:

Huang, Qingqing;
Ma, Yi

Publication type:

Article

Cover Image.

Published in:

NMR in Biomedicine, 2025, v. 38, n. 2, p. 1, doi. 10.1002/nbm.5326

By:

Khan, Muhammad H.;
Walsh, John J.;
Kurdi, Sara;
Mishra, Sandeep Kumar;
Mihailović, Jelena M.;
Coman, Daniel;
Hyder, Fahmeed

Publication type:

Article

Sorafenib Alters Interstitial Proton and Sodium Levels in the Tumor Microenvironment: A <sup>1</sup>H/<sup>23</sup>Na Spectroscopic Imaging Study.

Published in:

NMR in Biomedicine, 2025, v. 38, n. 2, p. 1, doi. 10.1002/nbm.5319

By:

Khan, Muhammad H.;
Walsh, John J.;
Kurdi, Sara;
Mishra, Sandeep Kumar;
Mihailović, Jelena M.;
Coman, Daniel;
Hyder, Fahmeed

Publication type:

Article

Quantitative evaluation of the efficacy and safety of first-line systemic therapies for advanced hepatocellular carcinoma.

Published in:

European Journal of Clinical Pharmacology, 2025, v. 81, n. 3, p. 383, doi. 10.1007/s00228-024-03797-0

By:

Wang, Xinrui;
Huang, Jihan;
Liu, Yixiao;
Wu, Lijuan;
Cai, Ruifen;
Zheng, Qingshan;
Li, Lujin

Publication type:

Article

Development and External Validation of the Munich Sorafenib Evaluation Score for Hepatocellular Carcinoma.

Published in:

Digestive Diseases, 2023, v. 41, n. 2, p. 268, doi. 10.1159/000524336

By:

op den Winkel, Mark;
Nagel, Dorothea;
Seidensticker, Max;
De Toni, Enrico N.;
Merz, Jessica;
op den Winkel, Jan;
Öcal, Osman;
Stecher, Stephanie-Susanne;
Bourhis, Hélène;
Malfertheiner, Peter;
Mayerle, Julia;
Ricke, Jens;
Kolligs, Frank T.

Publication type:

Article

Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art Review.

Published in:

Digestive Diseases, 2022, v. 40, n. 5, p. 565, doi. 10.1159/000520095

By:

Reiter, Florian P.;
Ben Khaled, Najib;
Ye, Liangtao;
Zhang, Changhua;
Seidensticker, Max;
op den Winkel, Mark;
Denk, Gerald;
Geier, Andreas;
De Toni, Enrico N.

Publication type:

Article

Sorafenib for Advanced Hepatocellular Carcinoma: A Real-Life Experience.

Published in:

Digestive Diseases, 2018, v. 36, n. 5, p. 377, doi. 10.1159/000490378

By:

Longo, Larisse;
de Freitas, Laura Bainy Rodrigues;
Santos, Deivid;
Grivicich, Ivana;
Álvares-da-Silva, Mário Reis

Publication type:

Article

Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib.

Published in:

Digestive Diseases, 2018, v. 36, n. 1, p. 78, doi. 10.1159/000477578

By:

Labenz, Christian;
Prenosil, Vera;
Koch, Sandra;
Huber, Yvonne;
Marquardt, Jens U.;
Schattenberg, Jörn M.;
Galle, Peter R.;
Weinmann, Arndt;
Wörns, Marcus-Alexander

Publication type:

Article

Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.

Published in:

Digestive Diseases, 2017, v. 35, n. 6, p. 602, doi. 10.1159/000480256

By:

Atsushi Hiraoka;
Takashi Kumada;
Masatoshi Kudo;
Masashi Hirooka;
Yohei Koizumi;
Yoichi Hiasa;
Kazuto Tajiri;
Hidenori Toyoda;
Toshifumi Tada;
Hironori Ochi;
Koji Joko;
Noritomo Shimada;
Akihiro Deguchi;
Toru Ishikawa;
Michitaka Imai;
Kunihiko Tsuji;
Kojiro Michitaka

Publication type:

Article

Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib.

Published in:

Digestive Diseases, 2017, v. 35, n. 6, p. 78, doi. 10.1159/000477578

By:

Labenz, Christian;
Prenosil, Vera;
Koch, Sandra;
Huber, Yvonne;
Marquardt, Jens U.;
Schattenberg, Jörn M.;
Galle, Peter R.;
Weinmann, Arndt;
Wörns, Marcus-Alexander

Publication type:

Article

Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute Experience.

Published in:

Digestive Diseases, 2017, v. 35, n. 6, p. 611, doi. 10.1159/000480257

By:

Kazuomi Ueshima;
Naoshi Nishida;
Masatoshi Kudo

Publication type:

Article

The Prognostic Significance of ACLR and HALP Scores in Hepatocellular Carcinoma Patients Treated with Sorafenib.

Published in:

Zagazig University Medical Journal, 2024, v. 30, n. 6, p. 2533, doi. 10.21608/zumj.2024.295419.3431

By:

Mohamed, Amrallah A.;
Shabana, Marwa Abo;
Mohamed, Yara Naser;
Bakry, Adel

Publication type:

Article

Impact of Prognostic Nutritional Index and Systemic Immune-Inflammation Index on the Clinical Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib.

Published in:

Zagazig University Medical Journal, 2023, v. 29, n. 2, p. 650, doi. 10.21608/zumj.2022.141934.2577

By:

Waley, Ahmad Barakat;
Haggag, Rasha;
Ahmed Barakat, Amir Abd-elhameed;
Rashied, Hanaa Ahmed;
Abdul-Saboor, Ahmed;
Esawy, Marwa Mohammed;
Orban, Yasser Ali;
Bakry, Adel

Publication type:

Article

Overcoming Hormone Resistance in Breast Cancer Cell Lines: The Impact of Combined Treatment with Sorafenib and Palbociclib on Cell Survival and Proliferation Pathways.

Published in:

Eurasian Journal of Medical Investigation, 2024, v. 8, n. 1, p. 13, doi. 10.14744/ejmi.2023.14963

By:

Almuradova, Elvina;
Kahraman, Erkan;
Goker, Erdem

Publication type:

Article

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors.

Published in:

Eurasian Journal of Medical Investigation, 2022, v. 6, n. 3, p. 326, doi. 10.14744/ejmi.2022.54998

By:

Paksoy, Nail;
Ferhatoglu, Ferhat;
Dogan, Izzet;
Ak, Naziye;
Pehlivan, Metin;
Ekenel, Meltem;
Basaran, Mert

Publication type:

Article

Long noncoding RNA DDX11-AS1 represses sorafenib-induced ferroptosis in hepatocellular carcinoma cells via Nrf2-Keap1 pathway.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01431-0

By:

Wang, Liang;
Wang, Liming

Publication type:

Article

Small molecule tyrosine kinase inhibitors approved for systemic therapy of advanced hepatocellular carcinoma: recent advances and future perspectives.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01110-0

By:

Liu, Jianzhong;
Xia, Shuai;
Zhang, Baoyi;
Mohammed, Dina Mostafa;
Yang, Xiangliang;
Zhu, Yanhong;
Jiang, Xinnong

Publication type:

Article

Interventional therapy combined with tyrosine kinase inhibitors with or without immune checkpoint inhibitors as initial treatment for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01026-9

By:

Du, Changjie;
Wu, Hongyu;
Zhong, Tao;
Zhai, Qilong;
Yuan, Jiajun;
Peng, Jialun;
Ma, Rong;
Li, Jinzheng

Publication type:

Article

Investigation of the apoptotic and cell cycle effects of sorafenib and doxorubicin on URG4/URGCP in leukemia cells.

Published in:

Pamukkale Medical Journal, 2024, v. 17, n. 3, p. 498, doi. 10.31362/patd.1476105

By:

Dodurga, Yavuz;
Elmas, Levent;
Seçme, Mücahit;
Demirkıran, Nazlı;
Avcı, Çığır Biray;
Bağcı, Gülseren;
Sağ, Sevda;
Tufan, Lale Şatıroğlu

Publication type:

Article

Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches.

Published in:

BMC Complementary Medicine & Therapies, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12906-023-03872-6

By:

El-Shehawy, Ashraf A.;
Elmetwalli, Alaa;
El-Far, Ali H.;
Mosallam, Sahar Abd El-Razik;
Salama, Afrah Fatthi;
Babalghith, Ahmad O.;
Mahmoud, Mohammad A.;
Mohany, Hany;
Gaber, Mohamed;
El-Sewedy, Tarek

Publication type:

Article

Effect of receptor protein kinase inhibition on the morphogenesis of experimental diabetic retinopathy.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2025, n. 1, p. 47, doi. 10.31288/oftalmolzh202514753

By:

K. O., Usenko

Publication type:

Article

Vascular Endothelial Growth Factor Inhibitors and the Risk of Aortic Aneurysm and Aortic Dissection.

Published in:

JAMA Network Open, 2024, v. 7, n. 3, p. e240940, doi. 10.1001/jamanetworkopen.2024.0940

By:

Wu, Chia-Wei;
Huang, Hsin-Yi;
Lin, Shin-Yi;
Wang, Chi-Chuan;
Huang, Chih-Fen;
Wu, I-Hui

Publication type:

Article

PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2.

Published in:

Journal of Liposome Research, 2019, v. 29, n. 4, p. 383, doi. 10.1080/08982104.2019.1570250

By:

Varshosaz, Jaleh;
Raghami, Fatemeh;
Rostami, Mahboubeh;
Jahanian, Ali

Publication type:

Article

RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1α–XBP1s pathway.

Published in:

Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00696-6

By:

Wang, Jia-Wei;
Ma, Li;
Liang, Yuan;
Yang, Xiao-Jun;
Wei, Song;
Peng, Hao;
Qiu, Shi-Pei;
Lu, Xu;
Zhu, Ya-Qing;
Wang, Bao-Lin

Publication type:

Article

MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 2, p. 171, doi. 10.3390/jcm8020171

By:

Turato, Cristian;
Fornari, Francesca;
Pollutri, Daniela;
Fassan, Matteo;
Quarta, Santina;
Villano, Gianmarco;
Ruvoletto, Mariagrazia;
Bolondi, Luigi;
Gramantieri, Laura;
Pontisso, Patrizia

Publication type:

Article

Methyl Palmitate—A suitable adjuvant for Sorafenib therapy to reduce in vivo toxicity and to enhance anti‐cancer effects on hepatocellular carcinoma cells.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2021, v. 128, n. 3, p. 366, doi. 10.1111/bcpt.13525

By:

Breeta, Raja David Isac Evangeline;
Grace, Viswanathan Mariammal Berlin;
Wilson, Devarajan David

Publication type:

Article

Cardiotoxicity of sorafenib is mediated through elevation of ROS level and CaMKII activity and dysregulation of calcium homoeostasis.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2020, v. 126, n. 2, p. 166, doi. 10.1111/bcpt.13318

By:

Ma, Wenzhuo;
Liu, Mei;
Liang, Fanfan;
Zhao, Lili;
Gao, Chenying;
Jiang, Xixi;
Zhang, Xin;
Zhan, Heqin;
Hu, Hao;
Zhao, Zhenghang

Publication type:

Article

Amygdalin Enhances the Antitumor Effect of Sorafenib.

Published in:

Egyptian Academic Journal of Biological Sciences. D, Histology & Histochemistry, 2021, v. 13, n. 2, p. 61, doi. 10.21608/EAJBSD.2021.196336

By:

Elmetwalli, Alaa;
Abdel Khalek, Aya M.;
El-Naggar, Sabry A.;
El- Magd, Mohammed A.;
Salama, Afrah F.

Publication type:

Article

Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.

Published in:

Gastroenterology Report, 2021, v. 9, n. 2, p. 133, doi. 10.1093/gastro/goaa042

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Ogawa, Chikara;
Tani, Joji;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Toyoda, Hidenori;
Ohama, Hideko

Publication type:

Article

Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells.

Published in:

Gastroenterology Report, 2020, v. 8, n. 6, p. 390, doi. 10.1093/gastro/goaa049

By:

Xu, Gui-Li;
Ni, Cai-Fang;
Liang, Han-Si;
Xu, Yun-Hua;
Wang, Wan-Sheng;
Shen, Jian;
Li, Ming-Ming;
Zhu, Xiao-Li

Publication type:

Article

Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells.

Published in:

Gastroenterology Report, 2020, v. 8, n. 5, p. 390, doi. 10.1093/gastro/goaa049

By:

Xu, Gui-Li;
Ni, Cai-Fang;
Liang, Han-Si;
Xu, Yun-Hua;
Wang, Wan-Sheng;
Shen, Jian;
Li, Ming-Ming;
Zhu, Xiao-Li

Publication type:

Article

Transarterial radioembolization with Yttrium-90: current status and future prospects.

Published in:

Gastroenterology Report, 2020, v. 8, n. 2, p. 164, doi. 10.1093/gastro/goz074

By:

Yang, Hua-Yu;
Jin, Bao;
Xu, Gang;
Sun, Le-Jia;
Du, Shun-Da;
Mao, Yi-Lei

Publication type:

Article

Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real‐world experience applying different CRP kinetics definitions

Published in:

Clinical & Translational Immunology, 2023, v. 12, n. 10, p. 1, doi. 10.1002/cti2.1471

By:

Hoeh, Benedikt;
Garcia, Cristina Cano;
Banek, Severine;
Klümper, Niklas;
Cox, Alexander;
Ellinger, Jörg;
Schmucker, Philipp;
Hahn, Oliver;
Mattigk, Angelika;
Zengerling, Friedemann;
Becker, Philippe;
Erdmann, Kati;
Buerk, Bjoern Thorben;
Flegar, Luka;
Huber, Johannes;
Kalogirou, Charis;
Zeuschner, Philip

Publication type:

Article

А SORAFENIB INDUCED MODEL OF GLOMERULAR KIDNEY DISEASE.

Published in:

Bulletin of Taras Shevchenko National University of Kyiv / Vestnik Kievskogo Nacional'Nogo Universiteta Imeni Tarasa Ševčenko, 2020, v. 81, n. 2, p. 25, doi. 10.17721/1728_2748.2020.81.25-31

By:

Stavniichuk, A.;
Savchuk, O.;
Khan, Abdul Hye;
Jankiewicz, Wojciech K.;
Imig, John D.

Publication type:

Article

А SORAFENIB INDUCED MODEL OF GLOMERULAR KIDNEY DISEASE.

Published in:

Bulletin of Taras Shevchenko National University of Kyiv / Vestnik Kievskogo Nacional'Nogo Universiteta Imeni Tarasa Ševčenko, 2020, v. 81, n. 2, p. 25, doi. 10.17721/1728_2748.2020.81.25-31

By:

Stavniichuk, A.;
Savchuk, O.;
Khan, Abdul Hye;
Jankiewicz, Wojciech K.;
Imig, John D.

Publication type:

Article

Lenvatinib in combination with transarterial chemoembolization vs. sorafenib in combination with transarterial chemoembolization for unresectable hepatocellular carcinoma: A network meta‑analysis.

Published in:

Oncology Letters, 2024, v. 28, n. 2, p. N.PAG, doi. 10.3892/ol.2024.14480

By:

Li, Yong;
Liu, Xingyu;
Liu, Junning;
Yang, Linfeng;
Wei, Song;
Li, Jijiang;
Gan, Huixin;
Ma, Ting;
Yi, Pengsheng

Publication type:

Article

Stress granules affect the sensitivity of renal cancer cells to sorafenib by sequestering and stabilizing COX‑2 mRNA.

Published in:

Oncology Letters, 2023, v. 25, n. 6, p. N.PAG, doi. 10.3892/ol.2023.13860

By:

Dai, Huiqi;
Wang, Guoli;
Cao, Wenmin;
Qi, Wei;
Chen, Wei;
Guo, Hongqian

Publication type:

Article

Comparative effectiveness of interventional therapeutic modalities for unresectable hepatocellular carcinoma: A systematic review and network meta-analysis.

Published in:

Oncology Letters, 2022, v. 24, n. 4, p. N.PAG

By:

Chen, Xin-Long;
Yu, Hai-Chuan;
Fan, Qi-Gang;
Yuan, Qi;
Jiang, Wen-Kai;
Rui, Shao-Zhen;
Zhou, Wen-Ce

Publication type:

Article

Tumor-treating fields in combination with sorafenib restrain the proliferation of liver cancer in vitro.

Published in:

Oncology Letters, 2022, v. 24, n. 4, p. N.PAG, doi. 10.3892/ol.2022.13458

By:

Jang, Yoonjung;
Lee, Won Seok;
Sai, Sei;
Kim, Jeong Yub;
Kim, Jong-Ki;
Kim, Eun Ho

Publication type:

Article

Hypoxia-inducible factor-1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma.

Published in:

Oncology Letters, 2022, v. 24, n. 2, p. N.PAG, doi. 10.3892/ol.2022.13404

By:

Chen, Huan;
Chen, Jing;
Yuan, Huixin;
Li, Xiuhui;
Li, Weihua

Publication type:

Article

Analysis of the expression, function and signaling of glycogen phosphorylase isoforms in hepatocellular carcinoma.

Published in:

Oncology Letters, 2022, v. 24, n. 2, p. N.PAG, doi. 10.3892/ol.2022.13364

By:

Jiang, Lingyu;
Liu, Shuyan;
Deng, Tingzhi;
Yang, Yang;
Zhang, Yin

Publication type:

Article

Sorafenib treatment of metastatic melanoma with c-Kit aberration reduces tumor growth and promotes survival.

Published in:

Oncology Letters, 2021, v. 22, n. 6, p. N.PAG, doi. 10.3892/ol.2021.13089

By:

Takeda, Tomoya;
Tsubaki, Masanobu;
Kato, Natsuki;
Genno, Shuji;
Ichimura, Eri;
Enomoto, Aya;
Imano, Motohiro;
Satou, Takao;
Nishida, Shozo

Publication type:

Article

Response of human cancer cells to simultaneous treatment with sorafenib and radiofrequency current.

Published in:

Oncology Letters, 2021, v. 22, n. 5, p. N.PAG

By:

Hernández-Bule, María Luisa;
Martínez, María Antonia;
Trillo, María Ángeles;
Martínez, Lidia;
Toledano-Macías, Elena;
Úbeda, Alejandro

Publication type:

Article

miR-425 regulates lipophagy via SIRT1 to promote sorafenib resistance in liver cancer.

Published in:

Oncology Letters, 2021, v. 22, n. 4, p. N.PAG, doi. 10.3892/ol.2021.12956

By:

Sun, Gongping;
Yang, Liang;
Wei, Shibo;
Jin, Hongyuan;
Li, Bowen;
Li, Hangyu

Publication type:

Article

A combination of sorafenib and radiotherapy reduces NF-κB activity and growth of hepatocellular carcinoma in an orthotopic mouse model.

Published in:

Oncology Letters, 2021, v. 21, n. 4, p. N.PAG, doi. 10.3892/ol.2021.12598

By:

Chuang, Hui-Yen;
Tyan, Yeu-Sheng;
Hwang, Jeng-Jong;
Shih, Kuang-Chung;
Lin, Wei-Chan

Publication type:

Article

Combination treatment of gemcitabine and sorafenib exerts a synergistic inhibitory effect on non-small cell lung cancer in vitro and in vivo via the epithelial-to-mesenchymal transition process.

Published in:

Oncology Letters, 2020, v. 20, n. 1, p. 346, doi. 10.3892/ol.2020.11536

By:

Jiang, Shanshan;
Wang, Rong;
Zhang, Xuan;
Wu, Feihua;
Li, Shengnan;
Yuan, Yongfang

Publication type:

Article

Potential synergistic effects of sorafenib and CP-31398 for treating anaplastic thyroid cancer with p53 mutations.

Published in:

Oncology Letters, 2020, v. 19, n. 4, p. 3021, doi. 10.3892/ol.2020.11377

By:

JIIN-TORNG WU;
CHING-LING LIN;
CHI-JUNG HUANG;
YU-CHE CHENG;
CHIH-CHENG CHIEN;
YUNG-CHUAN SUNG

Publication type:

Article

Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway.

Published in:

Oncology Letters, 2020, v. 19, n. 1, p. 323, doi. 10.3892/ol.2019.11066

By:

Li, Yu;
Yan, Hengyi;
Xu, Xiaoman;
Liu, Hongbo;
Wu, Cen;
Zhao, Li

Publication type:

Article

Artesunate and sorafenib: Combinatorial inhibition of liver cancer cell growth.

Published in:

Oncology Letters, 2019, v. 18, n. 5, p. 4735, doi. 10.3892/ol.2019.10810

By:

Li, Hao;
Xu, Kanghe;
Pian, Guangzhe;
Sun, Shu

Publication type:

Article